LISBON, Portgal—Drugmaker after drugmaker has touted data showing next-gen diabetes meds lower hypoglycemia risks—and new studies from Novo Nordisk show why. Type 2 diabetes patients who suffer severe hypoglycemia are four times more likely to die within 15 days—and twice
read moreThis year’s gala awards and dinner will take place at the London Marriott Hotel Grosvenor Square in Mayfair on Thursday 9 November. More: Marketer & Communications Team of the Year – venue announced! Source: News
read moreAstellas UK, Astellas Europe, Pfizer, Novartis Pharmaceuticals and Tor Generics named in advertisements More: Five firms named in breaches of ABPI code Source: News
read moreMany are also unaware of other initiatives to improve adoption of innovation More: Most HCPs not aware of Accelerated Access Review – report Source: News
read moreAmgen’s Mvasi is a biosimilar of Genentech’s Avastin More: FDA approves first cancer biosimilar Source: News
read moreAbbott More: Freestyle® Libre flash glucose monitoring technology gains reimbursement approval from the United Kingdom's national health service Source: MDlinx
read more© 1994 - 2026 B.M. Pharmaceuticals